Sun Pharma Acquires Checkpoint Therapeutics

This is a news story, published by Yahoo Finance, that relates primarily to Sun Pharmaceutical Industries Limited news.

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

Yahoo Finance news

For more news from Yahoo Finance, you can click here:

more news from Yahoo Finance

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

oncology company Checkpoint Therapeutics

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Checkpoint Therapeutics news, FDA marketing approval news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

US Cancer Firm Checkpoint Therapeutics

Benzinga

•

Health

India-Based Sun Pharma To Buy US Cancer Firm Checkpoint Therapeutics: Details

Summary

Nutrition label

73% Informative

Sun Pharmaceutical Industries Limited agreed to acquire U.S.-based immunotherapy and targeted oncology company Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) CKPT stock is up 64.2% at $ 4.055 at the last check Monday .

In December , the FDA approved Checkpoint's Unloxcyt (cosibelimab-ipdl) for metastatic cutaneous squamous cell carcinoma.

VR Score

Informative language

Neutral language

Article tone

formal

Language

English

Language complexity

Offensive language

not offensive

Hate speech